Elutia, Inc. is a biotechnology company focused on developing and commercializing innovative therapies that aim to address unmet medical needs. The company specializes in regenerative medicine, particularly in the areas of tissue engineering and cell therapy, working to create advanced solutions that enhance the body's natural healing processes. Through rigorous research and development, Elutia is dedicated to transforming the treatment landscape for various conditions, improving patient outcomes, and contributing to the advancement of healthcare technologies. Read More
Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's market cap stands at $2.2 million.
DALLAS, TX / ACCESSWIRE / July 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower portfolio companies.
